Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $185,520 | $163,632 | $153,084 | $170,179 |
| - Cash | $246 | $28,823 | $25,169 | $18,667 |
| + Debt | $12 | $1,280 | $1,280 | $1,280 |
| Enterprise Value | $185,286 | $136,089 | $129,195 | $152,792 |
| Revenue | $160 | $22,191 | $22,661 | $23,203 |
| % Growth | -99.3% | -2.1% | -2.3% | – |
| Gross Profit | $78 | $11,080 | $10,947 | $11,720 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| EBITDA | $33 | $3,263 | $2,690 | $3,520 |
| % Margin | 20.5% | 14.7% | 11.9% | 15.2% |
| Net Income | $22 | $4,519 | $3,121 | $3,591 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS Diluted | 0.53 | 107.87 | 72.91 | 82.99 |
| % Growth | -99.5% | 47.9% | -12.1% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |